DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home

Torben Biester, Judith Nir, Kerstin Remus, Alon Farfel, Ido Muller, Sarah Biester, Eran Atlas, Klemen Dovc, Nataša Bratina, Olga Kordonouri, Tadej Battelino, Moshe Philip, Thomas Danne, Revital Nimri

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science